ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Hypertension"

  • 2018 American Transplant Congress

    Antihypertensive Medication Use after Kidney Transplant: Practice Variation and Clinical Outcomes

    H. Yamout,1,2 R. Ouseph,1 M. Schnitzler,1 H. Xiao,1 V. Dharnidharka,3 A. Naik,4 N. Lam,5 F. Koraishy,1,2 H. Randall,1 D. Brennan,6 D. Segev,6 B. Kasiske,7 G. Hess,8 K. Lentine.1

    1Saint Louis Univ, St. Louis; 2St. Louis VA, St. Louis; 3Washington Univ, St. Louis; 4Univ Michigan, Ann Arbor, Canada; 5Univ Alberta, Edmonton; 6Johns Hopkins, Baltimore; 7Hennepin County, Minneapolis; 8Symphony Health, Conshohocken.

    Hypertension is common among kidney transplant (KTx) recipients, but the impact of antihypertensive medication (AHM) choice on patient and graft outcomes is not well defined.We…
  • 2018 American Transplant Congress

    CD40 Signaling in Proximal Tubules Regulates Fibrosis in Both Hypertension and Chronic Allograft Rejection

    V. Bletsos, J. Breidenbach, S. Haller, S. Stepkowski.

    University of Toledo College of Medicine and Life Sciences, Toledo, OH.

    Background: We explored the role of CD40 signaling in kidney proximal tubule epithelial cells on renal interstitial fibrosis (IF) in two models: hypertension; and chronic…
  • 2018 American Transplant Congress

    Evaluation of Salt Intake by 24-h Urinary Sodium Excretion in Kidney Transplant Patients

    T. Abe,1 M. Kawamura,1 S. Nakazawa,1 T. Kato,1 R. Imamura,1 N. Ichimaru,2 S. Takahara,2 N. Nonomura.1

    1Departments of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan; 2Departments of Advanced Technology for Transplantation, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

    Background: Dietary recommendations for chronic kidney disease advise 3 to 6 g/day of dietary salt intake. We evaluated current adherence to dietary recommendations for CKD…
  • 2018 American Transplant Congress

    Race/Ethnicity and Hypertension Self-Care Behaviors among US Living Kidney Donors

    M. Johnson, T. Purnell, X. Luo, L. Cooper, M. Waldram, D. Crews, M. Henderson, A. Massie, D. Segev.

    Johns Hopkins, Baltimore, MD.

    Purpose: Despite the success of live donor kidney transplantation as an optimal treatment for ESRD, some living kidney donors may be at increased risk of…
  • 2018 American Transplant Congress

    Krüppel-Like Factor 15 is a Key Suppressor of the Glomerular Epithelial Cell Fibrosis under Centrifugal Force Driven Pressure

    M. Yu,1 Y. Kim,1 H. Lee,1 J. Lee,2 R. Cha,3 C. Lee,4 Y. Kim,1 S. Yang.5

    1Seoul National University Hospital, Seoul, Korea; 2Seoul National University Boramae Medical Center, Seoul, Korea; 3National Medical Center, Seoul, Korea; 4Cheju Halla General Hospital, Jeju, Korea; 5Seoul National University Kidney Research Institue, Seoul, Korea.

    Hypertension is known to be responsible for a reduction in the number of functional nephrons of glomeruli due to fibrosis, which develops into a chronic…
  • 2018 American Transplant Congress

    Single versus Bilateral Simultaneous Nephrectomy during Kidney Transplantation in Autosomal Dominant Polycystic Kidney Disease

    C. Choi,1 S. Cho,1 M-.J. Cho,1 W. Cho,1 S. Ahn,1 S-.I. Min,1 S-.K. Min,1 S. Kim,2 J. Ha.1

    1Department of Surgery, Seoul National University College of Medicine, Seoul, Korea; 2Department of Surgery, Myongji Hospital, Goyang-si, Gyeonggi-Do, Korea.

    PurposeAlthough there are some controversies about nephrectomy in patient with autosomal dominant polycystic kidney disease (ADPKD), simultaneous nephrectomy has done selectively. There are few report…
  • 2018 American Transplant Congress

    Diagnostic Performance of Blood Pressure Measurement Modality in Prospective Living Kidney Donors

    S. Armanyous, M. Lioudis, G. Thomas, E. Poggio, J. Augustine.

    Nephrology, Cleveland Clinic, Cleveland, OH.

    Background: Precise blood pressure (BP) measurement to exclude hypertension (HTN) is critical in evaluating living kidney donors (LKDs). 24-hour ambulatory blood pressure monitoring (ABPM) is…
  • 2018 American Transplant Congress

    Renal Function, Blood Pressure, and Histologic Changes in Living Kidney Transplant Recipients from Hypertensive Donors

    T. Dienemann, J. Schellenberg, K. Amann, K. Heller, A. Weidemann.

    Nephrology and Hypertension University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany.

    Little is known if a kidney from a hypertensive donor performs equally compared to a kidney from a non-hypertensive donor. The present study examines the…
  • 2018 American Transplant Congress

    Nephrosclerosis beyond That Expected for Age is Predictive of Early New-Onset Hypertension (HTN) in Living Kidney Donors (LKD)

    N. Issa,1 L. Vaughan,1 A. Denic,1 V. Nagineni,1 H. Chakkera,2 J. Lieske,1 L. Lerman,1 S. Taler,1 M. Stegall,1 W. Kremers,1 E. Poggio,3 A. Rule.1

    1Mayo Clinic, Rochester, MN; 2Mayo Clinic, Scottsdale, AZ; 3Cleveland Clinic, Cleveland, OH.

    Background: Nephrosclerosis on biopsy (bx) of LKD is associated with older age & HTN. We studied whether nephrosclerosis is predictive of adverse changes early after…
  • 2017 American Transplant Congress

    Impact of Antihypertensive (AHT) Choice and Advagraf® Dose on Interstitial Fibrosis/Tubular Atrophy (IF/TA) and IF/TA Progression in Renal Allografts 24 Months Post-Transplantation (Tx).

    S. Cockfield,1 D. Rush,2 S. Wilson,3 J. Howell,4 FKC-014 Study Group.

    1University of Alberta Hospital, Edmonton, AB, Canada; 2Health Sciences Centre, Winnipeg, MB, Canada; 3Astellas Pharma Global Development, Northbrook, IL; 4Astellas Pharma Global Development, Markham, ON, Canada

    IF/TA may be delayed using ACEi- or ARB-type AHTs, which target the renin-angiotensin system (RAS), as well as by optimizing tacrolimus (TAC) exposure. The effect…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences